Savara, Inc. (SVRA)
4.67
+0.22
(+4.94%)
USD |
NASDAQ |
Oct 19, 13:18
Savara Cash from Operations (Annual) : -101.04M for Dec. 31, 2025
Cash from Operations (Annual) Chart
Historical Cash from Operations (Annual) Data
| Date | Value |
|---|---|
| December 31, 2025 | -101.04M |
| December 31, 2024 | -89.09M |
| December 31, 2023 | -51.06M |
| December 31, 2022 | -34.55M |
| December 31, 2021 | -40.08M |
| December 31, 2020 | -39.84M |
| December 31, 2019 | -45.12M |
| December 31, 2018 | -39.28M |
| December 31, 2017 | -28.23M |
| December 31, 2016 | -8.37M |
| December 31, 2015 | -32.95M |
| December 31, 2014 | -24.64M |
| December 31, 2013 | -17.79M |
| Date | Value |
|---|---|
| December 31, 2012 | -13.92M |
| December 31, 2011 | -13.47M |
| December 31, 2010 | -8.341M |
| December 31, 2009 | -12.62M |
| December 31, 2008 | -23.79M |
| December 31, 2007 | -19.64M |
| December 31, 2006 | -15.77M |
| December 31, 2005 | -11.65M |
| December 31, 2004 | -5.175M |
| December 31, 2003 | -2.247M |
| December 31, 2002 | -1.102M |
| December 31, 2001 | -1.711M |
| December 31, 2000 | -2.148M |
Cash From Operations Definition
Represents the net cash flow from the company's business operations.
Cash from Operations (Annual) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Cash from Operations (Annual) Benchmarks
| Gilead Sciences, Inc. | 10.02B |
| Insmed, Inc. | -935.01M |
| United Therapeutics Corp. | 1.561B |
| Vertex Pharmaceuticals, Inc. | 3.631B |
| ACADIA Pharmaceuticals, Inc. | 109.84M |